November 06, 2020
The Master Class XXI • 2020
Disclaimer
The recommendations provided from the authors were obtained on November 6, 2020. The opinions and recommendations do not necessarily accurately reflect the current state of affairs or the current advice the authors may choose to provide in the same circumstances. Please refer to the current guidelines or the Canadian Association of Gastroenterology (CAG) for up-to-date treatment options.
Learning Objectives
The educational objective of the Mentoring in IBD XXI program is to increase awareness of current developments and best practices in inflammatory bowel disease (IBD) management, promote collaboration among Canadian gastroenterologists, and optimize treatment of IBD.
Participants in this program will be able to:
- Explore new therapies in IBD with emphasis on individualized therapy and strategic sequencing
- Discuss treatment options in inflammatory bowel disease patients with cancer
- Examine the roles of therapeutic drug monitoring and individualized dosing across biologic agents